Mettler-Toledo International, Inc. MTD
1,511.64
(7.51)
(0.49%)
as of 25 Sep
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Indexes
indicate stock being part of an index
Mettler-Toledo International, Inc. (MTD) Free cash flow margin
Mettler-Toledo International, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 20.9%, down 0.2 percentage points from fiscal 2025 (21.1%). Over the past ten years it has ranged from 13.4% (fiscal 2016) to 22.7% (fiscal 2023); the current reading is higher than 73% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 21.1% | (1.29) |
| FY2024 | 22.4% | (0.37) |
| FY2023 | 22.7% | 3.91 |
| FY2022 | 18.8% | (2.82) |
| FY2021 | 21.7% | 1.06 |
| FY2020 | 20.6% | 3.72 |
| FY2019 | 16.9% | 2.21 |
| FY2018 | 14.7% | (0.05) |
| FY2017 | 14.7% | 1.27 |
| FY2016 | 13.4% | (1.52) |
Against its own ten years
Low 13.4%
High 22.7%
Ten-year median
18.8%
Current reading's percentile
73
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 27.2% |
| MTD Mettler-Toledo International, Inc. | 20.9% |
| ILMN Illumina, Inc. compare | 20.7% |
| A Agilent Technologies, Inc. compare | 17.2% |
| IQV IQVIA Holdings Inc. compare | 13.3% |
| DGX Quest Diagnostics Incorporated compare | 11.7% |
| LH Labcorp Holdings Inc. compare | 8.16% |
| WAT Waters Corporation compare | 7.89% |
| GH Guardant Health, Inc. compare | −20.4% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on MTD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement